Document ID: FDA-2022-N-0009-0001
Agency: fda
Document Type: Notice
Title: Statement of Organization, Functions, and Delegations of Authority
Posted Date: 2022-01-03T05:00Z

[Federal Register Volume 87, Number 1 (Monday, January 3, 2022)]
[Notices]
[Page 95]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28378]

[[Page 95]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Statement of Organization, Functions, and Delegations of 
Authority

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration's (FDA), Center for Food 
Safety and Applied Nutrition (CFSAN), including its Office of the 
Center Director (OCD), has modified their organizational structure. The 
new organizational structure was approved by the Deputy Secretary of 
Health and Human Services and effective on November 24, 2021.

FOR FURTHER INFORMATION CONTACT: Yashika Rahaman, Director, Office of 
Planning, Evaluation and Risk Management, Office of Finance, Budget, 
Acquisitions and Planning, FDA, 4041 Powder Mill Road, Beltsville, MD 
20705-4304, 301-796-3843.

I. Introduction

    Part D, Chapter D-B, (Food and Drug Administration), the Statement 
of Organization, Functions and Delegations of Authority for the 
Department of Health and Human Services (35 FR 3685, February 25, 1970, 
60 FR 56606, November 9, 1995, 64 FR 36361, July 6, 1999, 72 FR 50112, 
August 30, 2007, 74 FR 41713, August 18, 2009, 76 FR 45270, July 28, 
2011, and 84 FR 22854, May 20, 2019) is revised to reflect FDA's 
reorganization of CFSAN to elevate its OCD's International Affairs 
Staff to the Office of International Engagement.
    The primary purpose of this reorganization is to establish the 
Office of International Engagement (OIE) within CFSAN. With the 
establishment of OIE, the current structure of the International 
Affairs Staff (IAS) (currently under OCD) would dissolve and its 
resources and functions absorbed into OIE. OIE (currently IAS) would 
maintain its current roles and responsibilities as the Center's focal 
point for engaging in international activities.
    The establishment of the proposed OIE aligns with broader 
organizational initiatives and priorities due to the establishment of 
the Office of Global Policy and Strategy (OGPS) and the Associate 
Commissioner for Imported Food Safety in the Office of Food Policy and 
Response (OFPR). OIE (currently IAS) has primary responsibility for the 
Center's coordination of international engagement for all its mission 
areas and coordinates with OGPS and OFPR daily. The establishment of 
OIE will streamline and improve work processes for better effectiveness 
and efficiency. All OIE work activities cut across Foods program 
offices and agency lines and requires central coordination and support, 
and OIE, by having more prominence as an Office in the Center, will 
enhance this effort. Additionally, the efficiencies gained by the 
reorganization aligns with HHS Strategic Goal 5: Promote Effective and 
Efficient Management and Stewardship; Strategic Objective 5.1: Ensure 
responsible financial management and Strategic Objective 5.2: Manage 
human capital to achieve the HHS mission.
    The Food and Drug Administration's Center for Food Safety and 
Applied Nutrition's Office of the Center Director and Office of 
International Engagement has been restructured as follows:
    DCEA. ORGANIZATION. The Center for Food Safety and Applied 
Nutrition's, Office of the Center Director is headed by the Center 
Director and includes the following:

Office of the Center Director (DCEA)

    DCEO. ORGANIZATION. The Center for Food Safety and Applied 
Nutrition's, Office International Engagement is headed by the Director, 
Office of International Engagement, and includes the following:

Public Health and Trade Staff (DCEO1)
Regulatory Cooperation and Partnerships Staff (DCEO2)

II. Delegations of Authority

    Pending further delegation, directives, or orders by the 
Commissioner of Food and Drugs, all delegations and redelegations of 
authority made to officials and employees of affected organizational 
components will continue in them or their successors pending further 
redelegations, provided they are consistent with this reorganization.

III. Electronic Access

    This reorganization is reflected in FDA's Staff Manual Guide (SMG). 
Persons interested in seeing the complete Staff Manual Guide can find 
it on FDA's website at: https://www.fda.gov/AboutFDA/ReportsManualsForms/StaffManualGuides/default.htm.
    Authority: 44 U.S.C. 3101.

    Dated: October 22, 2021.
Andrea Palm,
Deputy Secretary of Health and Human Services.
[FR Doc. 2021-28378 Filed 12-30-21; 8:45 am]
BILLING CODE 4164-01-P